Related Experiment Videos
[Geriatric intervention in oncology for elderly patients].
1Service de gériatrie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France; Université Paris Descartes, 12, rue de l'École-de-Médecine, 75006 Paris, France.
Summary
Geriatric oncology integrates specialized care for elderly cancer patients, improving autonomy and mortality. Comprehensive geriatric assessment guides tailored cancer treatment, with new trials evaluating integrated care benefits.
Area of Science:
- Geriatric Oncology
- Oncology
- Geriatrics
Context:
- Over 50% of cancer diagnoses occur in individuals over 70 years old.
- National cancer plans advocate for geriatric oncology to ensure appropriate treatment based on patient frailty.
- Geriatric interventions have a 30-year history, with meta-analyses confirming benefits in autonomy and mortality.
Purpose:
- To highlight the importance of geriatric comprehensive assessment in cancer care for elderly patients.
- To emphasize the need for integrated geriatric care models in oncology.
- To introduce upcoming randomized trials evaluating geriatric integrated care for elderly cancer patients.
Summary:
- Geriatric oncology aims to provide tailored cancer treatments considering patient frailty.
- Geriatric comprehensive assessment offers crucial information for modifying cancer treatment plans.
- Integrated geriatric care models have shown benefits in autonomy and mortality for various patient groups.
Impact:
- Geriatric comprehensive assessment significantly informs cancer treatment decisions for elderly patients.
- The development of pilot oncogeriatric coordination units enhances patient and professional satisfaction.
- Future randomized trials will provide robust evidence on the impact of geriatric integrated care on mortality and quality of life in elderly cancer patients.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
357
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
357
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
324
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
324
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
344
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
344
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
326
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
326
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
321
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
321
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
813
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
813